Clinical trials (CT) are the long and complex processes for bringing novel medical products to patients through the regulatory process of evaluating the safety and
As new non-COVID-related clinical trials proliferate, the need for effective global decentralized CT management is becoming even more apparent. What is needed, says Dr. Harsha
JoTo PR Disruptors’ signs Jeeva Trials, a human-centric Software as a Service (SaaS) company that is working to revolutionize the clinical trials space at scale.
Clinical trials are expensive, take significant time, and can run into any number of challenges and delays. The average drug study will see a 30%
Source: PubsOnline Over the past two years, the testing of new medical devices, drugs and vaccines has increasingly been performed outside large medical centers. Faster
Source: ACRP There’s more to the quest of fostering diversity, equity, and inclusion in the delivery of clinical research opportunities than just reaching race/ethnicity-, gender-,
Maximizing Clinical Trial Access, Diversity, and Efficiency are Keys to Optimizing Orphan Drug Development February 22, 2022 February is Rare Disease Month—an important time when
Source: Insightcare By Harsha Rajasimha, PhD, Founder and CEO, Jeeva Clinical Trials Inc. www.jeevatrials.com To say that COVID-19 has been a challenge to healthcare systems
The COVID-19 pandemic brought a new sense of appreciation for clinical trials as masses watched clinical trials closely while pharmaceutical companies raced against the clock
The loss of his daughter to a rare congenital disorder in the United States and the passing of his younger brother in India from complications
